Table of Contents Author Guidelines Submit a Manuscript
Stem Cells International
Volume 2015 (2015), Article ID 150609, 10 pages
http://dx.doi.org/10.1155/2015/150609
Review Article

Umbilical Cord Tissue-Derived Cells as Therapeutic Agents

1National Taras Shevchenko University of Kyiv, Kyiv, Ukraine
2Hemafund Ltd., Lisozakhysna Street 5, Kyiv, Ukraine
3International Clinical Research Center, St. Anne’s University Hospital and Masaryk University, Pekarska 53, 656 91 Brno, Czech Republic

Received 31 August 2014; Accepted 21 November 2014

Academic Editor: Pritha Ray

Copyright © 2015 Olga Maslova et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Ankrum and J. M. Karp, “Mesenchymal stem cell therapy: two steps forward, one step back,” Trends in Molecular Medicine, vol. 16, no. 5, pp. 203–209, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. M. J. Hoogduijn, F. Popp, R. Verbeek et al., “The immunomodulatory properties of mesenchymal stem cells and their use for immunotherapy,” International Immunopharmacology, vol. 10, no. 12, pp. 1496–1500, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. Y.-L. Si, Y.-L. Zhao, H.-J. Hao, X.-B. Fu, and W.-D. Han, “MSCs: biological characteristics, clinical applications and their outstanding concerns,” Ageing Research Reviews, vol. 10, no. 1, pp. 93–103, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. A. I. Caplan and M. D. West, “Progressive approval: a proposal for a new regulatory pathway for regenerative medicine,” Stem Cells Translational Medicine, 2014. View at Publisher · View at Google Scholar
  5. S. Ma, N. Xie, W. Li, B. Yuan, Y. Shi, and Y. Wang, “Immunobiology of mesenchymal stem cells,” Cell Death and Differentiation, vol. 21, no. 2, pp. 216–225, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. K. Bieback and I. Brinkmann, “Mesenchymal stromal cells from human perinatal tissues: from biology to cell therapy,” World Journal of Stem Cells, vol. 2, no. 4, pp. 81–92, 2010. View at Google Scholar
  7. R. Hass, C. Kasper, S. Böhm, and R. Jacobs, “Different populations and sources of human mesenchymal stem cells (MSC): a comparison of adult and neonatal tissue-derived MSC,” Cell Communication and Signaling, vol. 9, article 12, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. K. D. McElreavey, A. I. Irvine, K. T. Ennis, and W. H. I. McLean, “Isolation, culture and characterisation of fibroblast-like cells derived from the Wharton's jelly portion of human umbilical cord,” Biochemical Society Transactions, vol. 19, no. 1, p. 29S, 1991. View at Google Scholar · View at Scopus
  9. B. Pelletier, M. Moisant, and J. P. Zahnd, “Primary cultures of epithelial cells and long-term cultures of fibroblasts from the human umbilical cord: ultrastructural and immunocytochemical characterization,” Comptes Rendus des Séances de la Société de Biologie et de ses Filiales, vol. 180, no. 4, pp. 447–459, 1986. View at Google Scholar · View at Scopus
  10. K. Takechi, Y. Kuwabara, and M. Mizuno, “Ultrastructural and immunohistochemical studies of Wharton's jelly umbilical cord cells,” Placenta, vol. 14, no. 2, pp. 235–245, 1993. View at Publisher · View at Google Scholar · View at Scopus
  11. A. K. Nanaev, G. Kohnen, A. P. Milovanov, S. P. Domogatsky, and P. Kaufmann, “Stromal differentiation and architecture of the human umbilical cord,” Placenta, vol. 18, no. 1, pp. 53–64, 1997. View at Publisher · View at Google Scholar · View at Scopus
  12. K. Kobayashi, T. Kubota, and T. Aso, “Study on myofibroblast differentiation in the stromal cells of Wharton's jelly. Expression and localization of α-smooth muscle actin,” Early Human Development, vol. 51, no. 3, pp. 223–233, 1998. View at Publisher · View at Google Scholar · View at Scopus
  13. H.-S. Wang, S.-C. Hung, S.-T. Peng et al., “Mesenchymal stem cells in the Wharton's jelly of the human umbilical cord,” Stem Cells, vol. 22, no. 7, pp. 1330–1337, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Karahuseyinoglu, O. Cinar, E. Kilic et al., “Biology of stem cells in human umbilical cord stroma: in situ and in vitro surveys,” Stem Cells, vol. 25, no. 2, pp. 319–331, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. D. L. Troyer and M. L. Weiss, “Wharton’s jelly-derived cells are a primitive stromal cell population,” Stem Cells, vol. 26, no. 3, pp. 591–599, 2008. View at Google Scholar · View at Scopus
  16. R. R. Taghizadeh, K. J. Cetrulo, and C. L. Cetrulo, “Wharton's Jelly stem cells: future clinical applications,” Placenta, vol. 32, no. 4, pp. S311–S315, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. D. T. Harris, “Stem cell banking for regenerative and personalized medicine,” Biomedicines, vol. 2, no. 1, pp. 50–79, 2014. View at Publisher · View at Google Scholar
  18. T. Meyer, A. Pfeifroth, and B. Hocht, “Isolation and characterisation of mesenchymal stem cells in Wharton's jelly of the human umbilical cord: potent cells for cellbased therapies in paediatric surgery?” European Surgery, vol. 40, pp. 239–244, 2008. View at Google Scholar
  19. A. Kikuchi-Taura, A. Taguchi, T. Kanda et al., “Human umbilical cord provides a significant source of unexpanded mesenchymal stromal cells,” Cytotherapy, vol. 14, no. 4, pp. 441–450, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. K. Bieback and H. Klüter, “Mesenchymal stromal cells from umbilical cord blood,” Current Stem Cell Research & Therapy, vol. 2, no. 4, pp. 310–323, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. V. Mirabet and P. Solves, “Cryopreservation of hematopoietic stem cells from umbilical cord blood for transplantation stem cells and cancer stem cells,” Journal of Stem Cell Research & Therapy, vol. 9, pp. 3–11, 2013. View at Google Scholar
  22. M. Zeddou, A. Briquet, B. Relic et al., “The umbilical cord matrix is a better source of mesenchymal stem cells (MSC) than the umbilical cord blood,” Cell Biology International, vol. 34, no. 7, pp. 693–701, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Dominici, K. Le Blanc, I. Mueller et al., “Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement,” Cytotherapy, vol. 8, no. 4, pp. 315–317, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. C.-Y. Fong, M. Richards, N. Manasi, A. Biswas, and A. Bongso, “Comparative growth behaviour and characterization of stem cells from human Wharton's jelly,” Reproductive BioMedicine Online, vol. 15, no. 6, pp. 708–718, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. S. Angelucci, M. Marchisio, F. Di Giuseppe et al., “Proteome analysis of human Wharton's jelly cells during in vitro expansion,” Proteome Science, vol. 8, article 18, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. C.-Y. Fong, L.-L. Chak, A. Biswas et al., “Human Wharton's jelly stem cells have unique transcriptome profiles compared to human embryonic stem cells and other mesenchymal stem cells,” Stem Cell Reviews and Reports, vol. 7, no. 1, pp. 1–16, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. D.-W. Kim, M. Staples, K. Shinozuka, P. Pantcheva, S.-D. Kang, and C. V. Borlongan, “Wharton's jelly-derived mesenchymal stem cells: phenotypic characterization and optimizing their therapeutic potential for clinical applications,” International Journal of Molecular Sciences, vol. 14, no. 6, pp. 11692–11712, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. S. J. Prasanna and V. S. Jahnavi, “Wharton's jelly mesenchymal stem cells as off-the-shelf cellular therapeutics: a closer look into their regenerative and immunomodulatory properties,” The Open Tissue Engineering and Regenerative Medicine Journal, vol. 4, no. 1, pp. 28–38, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. A. Bongso and C.-Y. Fong, “The therapeutic potential, challenges and future clinical directions of stem cells from the Wharton’s jelly of the human umbilical cord,” Stem Cell Reviews and Reports, vol. 9, no. 2, pp. 226–240, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. T. Nagamura-Inoue and H. He, “Umbilical cord-derived mesenchymal stem cells: their advantages and potential clinical utility,” World Journal of Stem Cells, vol. 6, no. 2, pp. 195–202, 2014. View at Publisher · View at Google Scholar
  31. M. T. Conconi, P. Burra, R. Di Liddo et al., “CD105(+) cells from Wharton's jelly show in vitro and in vivo myogenic differentiative potential,” International Journal of Molecular Medicine, vol. 18, no. 6, pp. 1089–1096, 2006. View at Google Scholar · View at Scopus
  32. Y. Xu, S. Huang, K. Ma, X. Fu, W. Han, and Z. Sheng, “Promising new potential for mesenchymal stem cells derived from human umbilical cord Wharton's jelly: sweat gland cell-like differentiative capacity,” Journal of Tissue Engineering and Regenerative Medicine, vol. 6, no. 8, pp. 645–654, 2012. View at Publisher · View at Google Scholar · View at Scopus
  33. M. Choi, H.-S. Lee, P. Naidansaren et al., “Proangiogenic features of Wharton's jelly-derived mesenchymal stromal/stem cells and their ability to form functional vessels,” The International Journal of Biochemistry & Cell Biology, vol. 45, no. 3, pp. 560–570, 2013. View at Publisher · View at Google Scholar · View at Scopus
  34. R. Tao, T. J. Sun, Y. Q. Han, G. Xu, J. Liu, and Y. F. Han, “Epimorphin-induced differentiation of human umbilical cord mesenchymal stem cells into sweat gland cells,” European Review for Medical and Pharmacological Sciences, vol. 18, no. 9, pp. 1404–1410, 2014. View at Google Scholar
  35. D. Campard, P. A. Lysy, M. Najimi, and E. M. Sokal, “Native umbilical cord matrix stem cells express hepatic markers and differentiate into hepatocyte-like cells,” Gastroenterology, vol. 134, no. 3, pp. 833–848, 2008. View at Publisher · View at Google Scholar · View at Scopus
  36. P.-C. Tsai, T.-W. Fu, Y.-M. A. Chen et al., “The therapeutic potential of human umbilical mesenchymal stem cells from Wharton's jelly in the treatment of rat liver fibrosis,” Liver Transplantation, vol. 15, no. 5, pp. 484–495, 2009. View at Publisher · View at Google Scholar · View at Scopus
  37. R. Anzalone, M. L. Iacono, S. Corrao et al., “New emerging potentials for human wharton's jelly mesenchymal stem cells: immunological features and hepatocyte-like differentiative capacity,” Stem Cells and Development, vol. 19, no. 4, pp. 423–438, 2010. View at Publisher · View at Google Scholar · View at Scopus
  38. M. Shi, Z. Zhang, R. Xu et al., “Human mesenchymal stem cell transfusion is safe and improves liver function in acute-on-chronic liver failure patients,” Stem Cells Translational Medicine, vol. 1, no. 10, pp. 725–731, 2012. View at Publisher · View at Google Scholar · View at Scopus
  39. L. Wang, J. Li, H. Liu et al., “A pilot study of umbilical cord-derived mesenchymal stem cell transfusion in patients with primary biliary cirrhosis,” Journal of Gastroenterology and Hepatology (Australia), vol. 28, no. 1, pp. 85–92, 2013. View at Publisher · View at Google Scholar · View at Scopus
  40. A. Kadner, S. P. Hoerstrup, J. Tracy et al., “Human umbilical cord cells: a new cell source for cardiovascular tissue engineering,” Annals of Thoracic Surgery, vol. 74, no. 4, pp. S1422–S1428, 2002. View at Publisher · View at Google Scholar · View at Scopus
  41. S. Corrao, G. La Rocca, M. Lo Iacono et al., “New frontiers in regenerative medicine in cardiology: the potential of Wharton's jelly mesenchymal stem cells,” Current Stem Cell Research & Therapy, vol. 8, no. 1, pp. 39–45, 2013. View at Publisher · View at Google Scholar · View at Scopus
  42. Y. López, B. Lutjemeier, K. Seshareddy et al., “Wharton's jelly or bone marrow mesenchymal stromal cells improve cardiac function following myocardial infarction for more than 32 weeks in a rat model: a preliminary report,” Current Stem Cell Research and Therapy, vol. 8, no. 1, pp. 46–59, 2013. View at Publisher · View at Google Scholar · View at Scopus
  43. D. S. Nascimento, D. Mosqueira, L. M. Sousa et al., “Human umbilical cord tissue-derived mesenchymal stromal cells attenuate remodeling after myocardial infarction by proangiogenic, antiapoptotic, and endogenous cell-activation mechanisms,” Stem Cell Research & Therapy, vol. 5, no. 1, article 5, 2014. View at Publisher · View at Google Scholar · View at Scopus
  44. T. Du, J. Cheng, L. Zhong et al., “The alleviation of acute and chronic kidney injury by human Wharton's jelly-derived mesenchymal stromal cells triggered by ischemia-reperfusion injury via an endocrine mechanism,” Cytotherapy, vol. 14, no. 10, pp. 1215–1227, 2012. View at Publisher · View at Google Scholar · View at Scopus
  45. M. Song, J. Heo, J. Y. Chun et al., “The paracrine effects of mesenchymal stem cells stimulate the regeneration capacity of endogenous stem cells in the repair of a bladder-outlet-obstruction-induced overactive bladder,” Stem Cells and Development, vol. 23, no. 6, pp. 654–663, 2014. View at Google Scholar
  46. M. L. Weiss, K. E. Mitchell, J. E. Hix et al., “Transplantation of porcine umbilical cord matrix cells into the rat brain,” Experimental Neurology, vol. 182, no. 2, pp. 288–299, 2003. View at Publisher · View at Google Scholar · View at Scopus
  47. Y.-S. Fu, Y.-T. Shih, Y.-C. Cheng, and M.-Y. Min, “Transformation of human umbilical mesenchymal cells into neurons in vitro,” Journal of Biomedical Science, vol. 11, no. 5, pp. 652–660, 2004. View at Publisher · View at Google Scholar · View at Scopus
  48. Y.-S. Fu, Y.-C. Cheng, M.-Y. A. Lin et al., “Conversion of human umbilical cord mesenchymal stem cells in Wharton's Jelly to dopaminergic neurons in vitro: potential therapeutic application for Parkinsonism,” Stem Cells, vol. 24, no. 1, pp. 115–124, 2006. View at Publisher · View at Google Scholar · View at Scopus
  49. M. L. Weiss, S. Medicetty, A. R. Bledsoe et al., “Human umbilical cord matrix stem cells: preliminary characterization and effect of transplantation in a rodent model of Parkinson's disease,” Stem Cells, vol. 24, no. 3, pp. 781–792, 2006. View at Publisher · View at Google Scholar · View at Scopus
  50. N. Joyce, G. Annett, L. Wirthlin, S. Olson, G. Bauer, and J. A. Nolta, “Mesenchymal stem cells for the treatment of neurodegenerative disease,” Regenerative Medicine, vol. 5, no. 6, pp. 933–946, 2010. View at Publisher · View at Google Scholar · View at Scopus
  51. D. Matsuse, M. Kitada, M. Kohama et al., “Human umbilical cord-derived mesenchymal stromal cells differentiate into functional schwann cells that sustain peripheral nerve regeneration,” Journal of Neuropathology & Experimental Neurology, vol. 69, no. 9, pp. 973–985, 2010. View at Publisher · View at Google Scholar · View at Scopus
  52. M. M. Carvalho, F. G. Teixeira, R. L. Reis, N. Sousa, and A. J. Salgado, “Mesenchymal stem cells in the umbilical cord: phenotypic characterization, secretome and applications in central nervous system regenerative medicine,” Current Stem Cell Research and Therapy, vol. 6, no. 3, pp. 221–228, 2011. View at Publisher · View at Google Scholar · View at Scopus
  53. H. Dongmei, L. Jing, X. Mei et al., “Clinical analysis of the treatment of spinocerebellar ataxia and multiple system atrophy-cerebellar type with umbilical cord mesenchymal stromal cells,” Cytotherapy, vol. 13, no. 8, pp. 913–917, 2011. View at Publisher · View at Google Scholar · View at Scopus
  54. L. Zhang, Y. Li, C. Zhang, M. Chopp, A. Gosiewska, and K. Hong, “Delayed administration of human umbilical tissue-derived cells improved neurological functional recovery in a rodent model of focal ischemia,” Stroke, vol. 42, no. 5, pp. 1437–1444, 2011. View at Publisher · View at Google Scholar · View at Scopus
  55. J. Dalous, J. Larghero, and O. Baud, “Transplantation of umbilical cord-derived mesenchymal stem cells as a novel strategy to protect the central nervous system: technical aspects, preclinical studies, and clinical perspectives.,” Pediatric research, vol. 71, no. 4, pp. 482–490, 2012. View at Publisher · View at Google Scholar · View at Scopus
  56. J.-Y. Hsieh, H.-W. Wang, S.-J. Chang et al., “Mesenchymal stem cells from human umbilical cord express preferentially secreted factors related to neuroprotection, neurogenesis, and angiogenesis,” PLoS ONE, vol. 8, no. 8, Article ID e72604, 2013. View at Publisher · View at Google Scholar · View at Scopus
  57. R. Taran, M. K. Mamidi, G. Singh et al., “In vitro and in vivo neurogenic potential of mesenchymal stem cells Isolated from different sources,” Journal of Biosciences, vol. 39, no. 1, pp. 157–169, 2014. View at Google Scholar
  58. L. Wang, K. Seshareddy, M. L. Weiss, and M. S. Detamore, “Effect of initial seeding density on human umbilical cord mesenchymal stromal cells for fibrocartilage tissue engineering,” Tissue Engineering A, vol. 15, no. 5, pp. 1009–1017, 2009. View at Publisher · View at Google Scholar · View at Scopus
  59. M. C. Arufe, A. de La Fuente, J. Mateos, I. Fuentes, F. J. de Toro, and F. J. Blanco, “Analysis of the chondrogenic potential and secretome of mesenchymal stem cells derived from human umbilical cord stroma,” Stem Cells and Development, vol. 20, no. 7, pp. 1199–1212, 2011. View at Publisher · View at Google Scholar · View at Scopus
  60. M. lo Iacono, R. Anzalone, S. Corrao et al., “Perinatal and wharton's jelly-derived mesenchymal stem cells in cartilage regenerative medicine and tissue engineering strategies,” Open Tissue Engineering and Regenerative Medicine Journal, vol. 4, no. 1, pp. 72–81, 2011. View at Publisher · View at Google Scholar · View at Scopus
  61. A. Tyndall and A. Uccelli, “Multipotent mesenchymal stromal cells for autoimmune diseases: teaching new dogs old tricks,” Bone Marrow Transplantation, vol. 43, no. 11, pp. 821–828, 2009. View at Publisher · View at Google Scholar · View at Scopus
  62. L. Mazzini, I. Ferrero, V. Luparello et al., “Mesenchymal stem cell transplantation in amyotrophic lateral sclerosis: a phase I clinical trial,” Experimental Neurology, vol. 223, no. 1, pp. 229–237, 2010. View at Publisher · View at Google Scholar · View at Scopus
  63. A. Uccelli and D. J. Prockop, “Why should mesenchymal stem cells (MSCs) cure autoimmune diseases?” Current Opinion in Immunology, vol. 22, no. 6, pp. 768–774, 2010. View at Publisher · View at Google Scholar · View at Scopus
  64. X. Liu, P. Zheng, X. Wang et al., “A preliminary evaluation of efficacy and safety of Wharton's jelly mesenchymal stem cell transplantation in patients with type 2 diabetes mellitus,” Stem Cell Research & Therapy, vol. 5, article 57, 2014. View at Publisher · View at Google Scholar · View at Scopus
  65. R. Shohara, A. Yamamoto, S. Takikawa et al., “Mesenchymal stromal cells of human umbilical cord Wharton's jelly accelerate wound healing by paracrine mechanisms,” Cytotherapy, vol. 14, no. 10, pp. 1171–1181, 2012. View at Publisher · View at Google Scholar · View at Scopus
  66. A. I. Arno, S. Amini-Nik, P. H. Blit et al., “Human Wharton's jelly mesenchymal stem cells promote skin wound healing through paracrine signaling,” Stem Cell Research and Therapy, vol. 5, no. 1, article 28, 2014. View at Publisher · View at Google Scholar · View at Scopus
  67. J. W. Lee, X. Fang, A. Krasnodembskaya, J. P. Howard, and M. A. Matthay, “Concise review: mesenchymal stem cells for acute lung injury: role of paracrine soluble factors,” Stem Cells, vol. 29, no. 6, pp. 913–919, 2011. View at Publisher · View at Google Scholar · View at Scopus
  68. D. J. Weiss, “Concise review: current status of stem cells and regenerative medicine in lung biology and diseases,” Stem Cells, vol. 32, no. 1, pp. 16–25, 2014. View at Publisher · View at Google Scholar · View at Scopus
  69. A. Can and S. Karahuseyinoglu, “Concise review: human umbilical cord stroma with regard to the source of fetus-derived stem cells,” Stem Cells, vol. 25, no. 11, pp. 2886–2895, 2007. View at Publisher · View at Google Scholar · View at Scopus
  70. R. Sarugaser, D. Lickorish, D. Baksh, M. M. Hosseini, and J. E. Davies, “Human umbilical cord perivascular (HUCPV) cells: a source of mesenchymal progenitors,” Stem Cells, vol. 23, no. 2, pp. 220–229, 2005. View at Publisher · View at Google Scholar · View at Scopus
  71. J. Ennis, C. Götherström, K. le Blanc, and J. E. Davies, “In vitro immunologic properties of human umbilical cord perivascular cells,” Cytotherapy, vol. 10, no. 2, pp. 174–181, 2008. View at Publisher · View at Google Scholar · View at Scopus
  72. K. Kita, G. G. Gauglitz, T. T. Phan, D. N. Herndon, and M. G. Jeschke, “Isolation and characterization of mesenchymal stem cells from the sub-amniotic human umbilical cord lining membrane,” Stem Cells and Development, vol. 19, no. 4, pp. 491–501, 2010. View at Publisher · View at Google Scholar · View at Scopus
  73. M. T. Conconi, R. D. Liddo, M. Tommasini, C. Calore, and P. P. Parnigotto, “Phenotype and differentiation potential of stromal populations obtained from various zones of human umbilical cord: an overview,” Open Tissue Engineering and Regenerative Medicine Journal, vol. 4, no. 1, pp. 6–20, 2011. View at Publisher · View at Google Scholar · View at Scopus
  74. C. J. Hayward, J. Fradette, T. Galbraith et al., “Harvesting the potential of the human umbilical cord: isolation and characterisation of four cell types for tissue engineering applications,” Cells Tissues Organs, vol. 197, no. 1, pp. 37–54, 2012. View at Publisher · View at Google Scholar · View at Scopus
  75. A. Petsa, S. Gargani, A. Felesakis, N. Grigoriadis, and I. Grigoriadis, “Effectiveness of protocol for the isolation of Wharton's Jelly stem cells in large-scale applications,” In Vitro Cellular and Developmental Biology—Animal, vol. 45, no. 10, pp. 573–576, 2009. View at Publisher · View at Google Scholar · View at Scopus
  76. I. Majore, P. Moretti, F. Stahl, R. Hass, and C. Kasper, “Growth and differentiation properties of mesenchymal stromal cell populations derived from whole human umbilical cord,” Stem Cell Reviews and Reports, vol. 7, no. 1, pp. 17–31, 2011. View at Publisher · View at Google Scholar · View at Scopus
  77. N. Tsagias, I. Koliakos, V. Karagiannis, M. Eleftheriadou, and G. G. Koliakos, “Isolation of mesenchymal stem cells using the total length of umbilical cord for transplantation purposes,” Transfusion Medicine, vol. 21, no. 4, pp. 253–261, 2011. View at Publisher · View at Google Scholar · View at Scopus
  78. A. Marmotti, S. Mattia, M. Bruzzone et al., “Minced umbilical cord fragments as a source of cells for orthopaedic tissue engineering: an in vitro study,” Stem Cells International, vol. 2012, Article ID 326813, 13 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  79. C. Mennan, K. Wright, A. Bhattacharjee, B. Balain, J. Richardson, and S. Roberts, “Isolation and characterisation of mesenchymal stem cells from different regions of the human umbilical cord,” BioMed Research International, vol. 2013, Article ID 916136, 8 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  80. U. Nekanti, V. B. Rao, A. G. Bahirvani, M. Jan, S. Totey, and M. Ta, “Long-term expansion and pluripotent marker array analysis of Wharton's jelly-derived mesenchymal stem cells,” Stem Cells and Development, vol. 19, no. 1, pp. 117–130, 2010. View at Publisher · View at Google Scholar · View at Scopus
  81. C. Tantrawatpan, S. Manochantr, P. Kheolamai, Y. U-pratya, A. Supokawe, and S. Issaragrisil, “Pluripotent gene expression in mesenchymal stem cells from human umbilical cord Wharton's jelly and their differentiation potential to neural-like cells,” Journal of the Medical Association of Thailand, vol. 96, no. 9, pp. 1208–1217, 2013. View at Google Scholar · View at Scopus
  82. T. Pirjali, N. Azarpira, M. Ayatollahi, M. H. Aghdaie, B. Geramizadeh, and T. Talai, “Isolation and characterization of human mesenchymal stem cells derived from human umbilical cord Wharton's jelly and amniotic membrane,” International Journal of Organ Transplantation Medicine, vol. 4, no. 3, pp. 111–116, 2013. View at Google Scholar
  83. J. M. Ryan, A. R. Pettit, P. V. Guillot, J. K. Y. Chan, and N. M. Fisk, “Unravelling the pluripotency paradox in fetal and placental mesenchymal stem cells: Oct-4 expression and the case of the emperor's new clothes,” Stem Cell Reviews and Reports, vol. 9, no. 4, pp. 408–421, 2013. View at Publisher · View at Google Scholar · View at Scopus
  84. H. He, T. Nagamura-Inoue, H. Tsunoda et al., “Stage-specific embryonic antigen 4 in wharton's jelly-derived mesenchymal stem cells is not a marker for proliferation and multipotency,” Tissue Engineering Part A, vol. 20, no. 7-8, pp. 1314–1324, 2014. View at Publisher · View at Google Scholar · View at Scopus
  85. O. O. Maslova, N. S. Shuvalova, O. M. Sukhorada et al., “Heterogeneity of umbilical cords as a source for mesenchymal stem cells,” Dataset Papers in Biology, vol. 2013, Article ID 370103, 4 pages, 2013. View at Publisher · View at Google Scholar
  86. C.-Y. Fong, A. Biswas, A. Subramanian, A. Srinivasan, M. Choolani, and A. Bongso, “Human keloid cell characterization and inhibition of growth with human Wharton's jelly stem cell extracts,” Journal of Cellular Biochemistry, vol. 115, pp. 826–838, 2014. View at Google Scholar
  87. C.-Y. Fong, K. Tam, S. Cheyyatraivendran et al., “Human Wharton's jelly stem cells and its conditioned medium enhance healing of excisional and diabetic wounds,” Journal of Cellular Biochemistry, vol. 115, no. 2, pp. 290–302, 2014. View at Publisher · View at Google Scholar · View at Scopus
  88. H. Hao, G. Chen, J. Liu et al., “Culturing on wharton's jelly extract delays mesenchymal stem cell senescence through p53 and p16INK4a/pRb pathways,” PLoS ONE, vol. 8, no. 3, Article ID e58314, 2013. View at Publisher · View at Google Scholar · View at Scopus
  89. C. Y. Fong, K. Gauthaman, S. Cheyyatraivendran, H. D. Lin, A. Biswas, and A. Bongso, “Human umbilical cord Wharton's jelly stem cells and its conditioned medium support hematopoietic stem cell expansion ex vivo,” Journal of Cellular Biochemistry, vol. 113, no. 2, pp. 658–668, 2012. View at Publisher · View at Google Scholar · View at Scopus
  90. L.-L. Lu, Y.-J. Liu, S.-G. Yang et al., “Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials,” Haematologica, vol. 91, no. 8, pp. 1017–1028, 2006. View at Google Scholar · View at Scopus
  91. X. Fan, F. P. Gay, S.-Y. Ong et al., “Mesenchymal stromal cell supported umbilical cord blood ex vivo expansion enhances regulatory T cells and reduces graft versus host disease,” Cytotherapy, vol. 15, no. 5, pp. 610–619, 2013. View at Publisher · View at Google Scholar · View at Scopus
  92. H. D. Lin, A. Bongso, K. Gauthaman, A. Biswas, M. Choolani, and C.-Y. Fong, “Human Wharton's jelly stem cell conditioned medium enhances freeze-thaw survival and expansion of cryopreserved CD34+ cells,” Stem Cell Reviews and Reports, pp. 1–12, 2013. View at Publisher · View at Google Scholar · View at Scopus
  93. I. Scheers, C. Lombard, M. Najimi, and E. M. Sokal, “Cell therapy for the treatment of metabolic liver disease: an update on the umbilical cord derived stem cells candidates,” Open Tissue Engineering and Regenerative Medicine Journal, vol. 4, no. 1, pp. 48–53, 2011. View at Publisher · View at Google Scholar · View at Scopus
  94. O. V. Semenov and C. Breymann, “Mesenchymal stem cells derived from wharton's jelly and their potential for cardio-vascular tissue engineering,” The Open Tissue Engineering and Regenerative Medicine Journal, vol. 4, no. 1, pp. 64–71, 2011. View at Publisher · View at Google Scholar · View at Scopus
  95. M. L. Weiss, C. Anderson, S. Medicetty et al., “Immune properties of human umbilical cord Wharton's jelly-derived cells,” Stem Cells, vol. 26, no. 11, pp. 2865–2874, 2008. View at Publisher · View at Google Scholar · View at Scopus
  96. M. Stubbendorff, T. Deuse, X. Hua et al., “Immunological properties of extraembryonic human mesenchymal stromal cells derived from gestational tissue,” Stem Cells and Development, vol. 22, no. 19, pp. 2619–2629, 2013. View at Publisher · View at Google Scholar · View at Scopus
  97. J. Voswinkel, S. Francois, J.-M. Simon et al., “Use of mesenchymal stem cells (MSC) in chronic inflammatory fistulizing and fibrotic diseases: a comprehensive review,” Clinical Reviews in Allergy & Immunology, vol. 45, no. 2, pp. 180–192, 2013. View at Publisher · View at Google Scholar · View at Scopus
  98. R. S. Rachakatla, M. M. Pyle, R. Ayuzawa et al., “Combination treatment of human umbilical cord matrix stem cell-based interferon-beta gene therapy and 5-fluorouracil significantly reduces growth of metastatic human breast cancer in SCID mouse lungs,” Cancer Investigation, vol. 26, no. 7, pp. 662–670, 2008. View at Publisher · View at Google Scholar · View at Scopus
  99. M. R. Loebinger and S. M. Janes, “Stem cells as vectors for antitumour therapy,” Thorax, vol. 65, no. 4, pp. 362–369, 2010. View at Publisher · View at Google Scholar · View at Scopus
  100. C. K. Tong, S. Vellasamy, B. C. Tan et al., “Generation of mesenchymal stem cell from human umbilical cord tissue using a combination enzymatic and mechanical disassociation method,” Cell Biology International, vol. 35, no. 3, pp. 221–226, 2011. View at Publisher · View at Google Scholar · View at Scopus
  101. I. Koliakos, N. Tsagias, and V. Karagiannis, “Mesenchymal cells isolation from Wharton's jelly, in perspective to clinical applications,” Journal of Biological Research, vol. 16, pp. 194–201, 2011. View at Google Scholar · View at Scopus
  102. P. Venugopal, S. Balasubramanian, A. S. Majumdar, and M. Ta, “Isolation, characterization, and gene expression analysis of Wharton's jelly-derived mesenchymal stem cells under xeno-free culture conditions,” Stem Cells and Cloning: Advances and Applications, vol. 4, no. 1, pp. 39–50, 2011. View at Publisher · View at Google Scholar · View at Scopus
  103. P. Salehinejad, N. Banu Alitheen, A. M. Ali et al., “Comparison of different methods for the isolation of mesenchymal stem cells from human umbilical cord Wharton's jelly,” In Vitro Cellular and Developmental Biology—Animal, vol. 48, no. 2, pp. 75–83, 2012. View at Publisher · View at Google Scholar · View at Scopus
  104. S. Sart, Y.-J. Schneider, Y. Li, and S. N. Agathos, “Stem cell bioprocess engineering towards cGMP production and clinical applications,” Cytotechnology, vol. 66, no. 5, pp. 709–722, 2014. View at Publisher · View at Google Scholar · View at Scopus
  105. B. Arjmand and H. R. Aghayan, “Cell manufacturing for clinical applications,” STEM CELLS, vol. 32, no. 9, pp. 2557–2558, 2014. View at Publisher · View at Google Scholar
  106. B. M. Deasy, J. E. Anderson, and S. Zelina, Regulatory Issues in the Therapeutic Use of Stem Cells, InTech, 2013.
  107. L. Sensebé, M. Gadelorge, and S. Fleury-Cappellesso, “Production of mesenchymal stromal/stem cells according to good manufacturing practices: a review,” Stem Cell Research and Therapy, vol. 4, no. 3, article 66, 2013. View at Publisher · View at Google Scholar · View at Scopus
  108. B. Philippe, S. Luc, P.-B. Valérie, R. Jérôme, B.-R. Alessandra, and C. Louis, “Culture and use of mesenchymal stromal cells in phase I and II clinical trials,” Stem Cells International, vol. 2010, Article ID 503593, 8 pages, 2010. View at Publisher · View at Google Scholar · View at Scopus
  109. L. Sensebé, P. Bourin, and K. Tarte, “Good manufacturing practices production of mesenchymal stem/stromal cells,” Human Gene Therapy, vol. 22, no. 1, pp. 19–26, 2011. View at Publisher · View at Google Scholar · View at Scopus
  110. C. A. Herberts, M. S. G. Kwa, and H. P. H. Hermsen, “Risk factors in the development of stem cell therapy,” Journal of Translational Medicine, vol. 9, article 29, 2011. View at Publisher · View at Google Scholar · View at Scopus
  111. A. Inamdar, “Therapeutic application of clinical grade umbilical cord tissue derived mesenchymal stem cells for human diseases,” Journal of Stem Cell Research & Therapy, vol. 3, article 5, 2013. View at Google Scholar
  112. J. P. Martins, J. M. Santos, J. M. D. Almeida et al., “Towards an advanced therapy medicinal product based on mesenchymal stromal cells isolated from the umbilical cord tissue: quality and safety data,” Stem Cell Research & Therapy, vol. 5, article 9, 2014. View at Publisher · View at Google Scholar · View at Scopus
  113. S. Roy, S. Arora, P. Kumari, and M. Ta, “A simple and serum-free protocol for cryopreservation of human umbilical cord as source of Wharton's jelly mesenchymal stem cells,” Cryobiology, vol. 68, no. 3, pp. 467–472, 2014. View at Publisher · View at Google Scholar · View at Scopus
  114. F. Di Giuseppe, L. Pierdomenico, E. Eleuterio et al., “Cryopreservation effects on Wharton's jelly stem cells proteome,” Stem Cell Reviews and Reports, vol. 10, no. 3, pp. 429–446, 2014. View at Publisher · View at Google Scholar · View at Scopus
  115. C. Menard, L. Pacelli, G. Bassi et al., “Clinical-grade mesenchymal stromal cells produced under various good manufacturing practice processes differ in their immunomodulatory properties: standardization of immune quality controls,” Stem Cells and Development, vol. 22, no. 12, pp. 1789–1801, 2013. View at Publisher · View at Google Scholar · View at Scopus
  116. P. Wuchter, W. Wagner, and A. D. Ho, “Mesenchymal stem cells: an oversimplified nomenclature for extremely heterogeneous progenitors,” Regenerative Medicine, vol. 3, no. 3, pp. 377–395, 2011. View at Google Scholar
  117. O. O. Maslova, “Current view of mesenchymal stem cells biology (brief review),” Biopolymers and Cell, vol. 28, no. 3, pp. 190–198, 2012. View at Publisher · View at Google Scholar · View at Scopus
  118. V. A. Kordium, V. I. Andrienko, O. A. Maslova et al., “Fundamental gap in fundamental biology,” Biopolymers and Cell, vol. 27, no. 3, pp. 235–245, 2011. View at Publisher · View at Google Scholar · View at Scopus
  119. S. Mechiche Alami, F. Velard, F. Draux et al., “Gene screening of Wharton's jelly derived stem cells,” Bio-Medical Materials and Engineering, vol. 24, no. 1, supplement, pp. 53–61, 2014. View at Publisher · View at Google Scholar